You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 235 No. 11, March 15, 1976 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (129)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Large-Dose Bleomycin Therapy and Pulmonary Toxicity

A Possible Role of Prior Radiotherapy

Melvin L. Samuels, MD; Douglas E. Johnson, MD; Paul Y. Holoye, MD; Victor J. Lanzotti, MD

JAMA. 1976;235(11):1117-1120.


Abstract

Bleomycin sulfate pulmonary toxicity was encountered in nine of 101 patients receiving high-dose therapy for widespread testicular cancer. The pulmonary presentation was separable into two categories: (1) an early or minimal form with dyspnea on exertion, minimal roentgenographic findings, and normal arterial partial pressure of oxygen at rest and (2) a severe form, with prominent roentgenographic findings and hypoxemia at rest. All five patients with the severe form died, while the remaining four patients with the minimal presentation recovered. Prior thoracic radiotherapy appeared to predispose to bleomycin pulmonary toxicity, as this complication developed in five of 12 patients receiving prior chest radiotherapy vs four of 89 not receiving radiotherapy (P<.001). The fatality rate of 5% with high-dose bleomycin therapy is acceptable in view of the 75% response rate and substantially improved survival achieved with bleomycin combination chemotherapy in metastatic testicular cancer.

(JAMA 235:1117-1120, 1976)



Author Affiliations

From the Department of Medicine (Drs Samuels, Holoye, and Lanzotti) and the Department of Surgery (Dr Johnson), the University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute at Houston.


Footnotes

Reprint requests to Section of General Medicine and Clinical Oncology, the University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute at Houston, Houston, TX 77025 (Dr Samuels).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Bleomycin-Induced Pneumonitis
Sleijfer
Chest 2001;120:617-624.
ABSTRACT | FULL TEXT  

Corticosteroids in Acute Respiratory Failure
JANTZ and SAHN
Am. J. Respir. Crit. Care Med. 1999;160:1079-1100.
FULL TEXT  

Long-Term Survivors of Childhood Cancer: The Late Effects of Therapy
Schwartz
The Oncologist 1999;4:45-54.
ABSTRACT | FULL TEXT  

Long-Term Complications of Antineoplastic Agents
Davis
Journal of Pharmacy Practice 1991;4:131-150.
 

Excess Prevalence of Pneumocystis carinii Pneumonia in Patients Treated for Lymphoma with Combination Chemotherapy
BROWNE et al.
ANN INTERN MED 1986;104:338-344.
ABSTRACT  

Reversibility of Severe Bleomycin-lnduced Pneumonitis
Brown et al.
JAMA 1978;239:2012-2014.
ABSTRACT  

Bleomycin Hypersensitivity Pneumonitis
HOLOYE et al.
ANN INTERN MED 1978;88:47-49.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.